Assessment Of Anterior Chamber Configuration Changes After Phacoemulsification

NCT ID: NCT02238002

Last Updated: 2014-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

64 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-12-31

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate changes in anterior chamber angle configuration after phacoemulsification and intraocular lens (IOL) implantation with Swept-Source Optical Coherence Tomography (SS-OCT).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To investigate changes in anterior chamber angle configuration after phacoemulsification and intraocular lens (IOL) implantation in eyes with a shallow anterior chamber and narrow angle, compared with the eyes with normal anterior chamber and open angle using Swept-Source Optical Coherence Tomography (SS-OCT).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract Shallow Anterior Chamber Narrow Angle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

normal angle

normal anterior chamber and open angle eyes underwent cataract surgery

cataract surgery

Intervention Type PROCEDURE

The patients of both groups underwent cataract surgery

narrow angle

shallow anterior chamber and narrow angle eyes underwent cataract surgery

cataract surgery

Intervention Type PROCEDURE

The patients of both groups underwent cataract surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cataract surgery

The patients of both groups underwent cataract surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

ACD was less than 2.68mm. the anterior chamber angle width on gonioscopy≤Shaffer 2 .

Exclusion Criteria

primary or secondary glaucoma, peripheral anterior synechiae, history of ocular surgeries
Minimum Eligible Age

45 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zheng Qian

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zheng Qian

Wenzhou Medical University

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yun e Zhao, MD

Role: PRINCIPAL_INVESTIGATOR

Wenzhou Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Eye Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Qian Zheng, MD

Role: CONTACT

18367839685

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Qian Zheng

Role: primary

18367839685

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WZMC2013QQFYJ

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.